国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2014年
15期
2332-2335
,共4页
α-硫辛酸%2型糖尿病%糖尿病周围神经病变%甲钴胺
α-硫辛痠%2型糖尿病%糖尿病週圍神經病變%甲鈷胺
α-류신산%2형당뇨병%당뇨병주위신경병변%갑고알
α-lipoic acid%Type 2 diabetes mellitus%Diabetic peripheral neuropathy (DPN)%Mecobalamin
目的 观察α-硫辛酸联合甲钴胺治疗2型糖尿病患者糖尿病周围神经病变(DPN)的疗效.方法 符合入选条件的DPN患者68例,随机分为观察组与对照组,每组各34例.观察组给予α-硫辛酸600 mg/d静脉滴注及甲钴胺500μg/d静脉滴注,对照组给予甲钴胺500μg/d静脉滴注,共治疗3周.在治疗前、治疗后分别进行神经病变主觉症状问卷(TSS)评分及神经传导速度测定并观察有无药物不良反应.结果 组内比较:与治疗前相比,两组患者治疗后TSS评分均有下降(P<0.01),神经传导速度均有加快(P<0.01);组间比较:治疗后观察组患者TSS评分下降比对照组显著,两组比较差异有统计学意义(P<0.05),治疗后两组患者神经传导速度比较差异无统计学意义(P>0.05).两组均未见严重药物不良反应.结论 α-硫辛酸与甲钴胺联合治疗能有效且安全地治疗2型糖尿病患者DPN,联合治疗对DPN阳性症状的改善作用优于甲钴胺单药治疗.
目的 觀察α-硫辛痠聯閤甲鈷胺治療2型糖尿病患者糖尿病週圍神經病變(DPN)的療效.方法 符閤入選條件的DPN患者68例,隨機分為觀察組與對照組,每組各34例.觀察組給予α-硫辛痠600 mg/d靜脈滴註及甲鈷胺500μg/d靜脈滴註,對照組給予甲鈷胺500μg/d靜脈滴註,共治療3週.在治療前、治療後分彆進行神經病變主覺癥狀問捲(TSS)評分及神經傳導速度測定併觀察有無藥物不良反應.結果 組內比較:與治療前相比,兩組患者治療後TSS評分均有下降(P<0.01),神經傳導速度均有加快(P<0.01);組間比較:治療後觀察組患者TSS評分下降比對照組顯著,兩組比較差異有統計學意義(P<0.05),治療後兩組患者神經傳導速度比較差異無統計學意義(P>0.05).兩組均未見嚴重藥物不良反應.結論 α-硫辛痠與甲鈷胺聯閤治療能有效且安全地治療2型糖尿病患者DPN,聯閤治療對DPN暘性癥狀的改善作用優于甲鈷胺單藥治療.
목적 관찰α-류신산연합갑고알치료2형당뇨병환자당뇨병주위신경병변(DPN)적료효.방법 부합입선조건적DPN환자68례,수궤분위관찰조여대조조,매조각34례.관찰조급여α-류신산600 mg/d정맥적주급갑고알500μg/d정맥적주,대조조급여갑고알500μg/d정맥적주,공치료3주.재치료전、치료후분별진행신경병변주각증상문권(TSS)평분급신경전도속도측정병관찰유무약물불량반응.결과 조내비교:여치료전상비,량조환자치료후TSS평분균유하강(P<0.01),신경전도속도균유가쾌(P<0.01);조간비교:치료후관찰조환자TSS평분하강비대조조현저,량조비교차이유통계학의의(P<0.05),치료후량조환자신경전도속도비교차이무통계학의의(P>0.05).량조균미견엄중약물불량반응.결론 α-류신산여갑고알연합치료능유효차안전지치료2형당뇨병환자DPN,연합치료대DPN양성증상적개선작용우우갑고알단약치료.
Objective To observe the efficacy of α-lipoic acid in combination with mecobalamin for diabetic peripheral neuropathy (DPN) in patients with type 2 diabetes mellitus.Methods 68 patients with DPN were randomly divided into observation group and control group with each group of 34 cases.The observation group received α-lipoic acid 600 mg/d and mecobalamin 500 μ g/d by intravenous drip for 3 weeks,and the control group received mecobalamin 500 μ g/d by intravenous drip for 3 weeks.Before treatment and after treatment,their total symptoms score (TSS) and nerve conductive velocity were measured and compared,and the side effects of drugs were observed.Results Compared with that before treatment,the TSS was decreased and nerve conductive velocity was accelerated significantly after 3 weeks of treatment in both groups (all P < 0.01).Compared with the control group,the TSS decrease of the observation group was more obvious after treatment and the difference was significant in statistics (P < 0.05).There was no significant difference in nerve conductive velocity between the two groups after the treatment (P > 0.05).The serious side effects were not found in both groups.Conclusion α-lipoic acid in combination with mecobalamin is effective and safe in the treatment of DPN in patients with type 2 diabetes mellitus.The combined therapy of α-lipoic acid and mecobalamin is better than single mecobalamin for the improvement of DPN symptoms.